Ryan Westergaard
Overview
Explore the profile of Ryan Westergaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tsui J, Whitney B, Korthuis P, Chan B, Pho M, Jenkins W, et al.
Drug Alcohol Depend
. 2023 Aug;
250:110911.
PMID: 37549545
Background: Methamphetamine use is common among persons with opioid use disorder. This study evaluated associations between methamphetamine use and treatment with agonist medications for opioid use disorder (MOUD, specifically buprenorphine,...
12.
DeJonge P, Lambrou A, Segaloff H, Bateman A, Sterkel A, Griggs C, et al.
BMC Infect Dis
. 2023 Jun;
23(1):374.
PMID: 37277736
Background: University students commonly received COVID-19 vaccinations before returning to U.S. campuses in the Fall of 2021. Given likely immunologic variation among students based on differences in type of primary...
13.
Dunajcik A, Haire K, Thomas J, Moriarty L, Springer Y, Villanueva J, et al.
PLOS Glob Public Health
. 2023 Mar;
3(3):e0001252.
PMID: 36989218
The first three SARS-CoV-2 phylogenetic lineages classified as variants of concern (VOCs) in the United States (U.S.) from December 15, 2020 to February 28, 2021, Alpha (B.1.1.7), Beta (B.1.351), and...
14.
Riemersma K, Haddock 3rd L, Wilson N, Minor N, Eickhoff J, Grogan B, et al.
PLoS Pathog
. 2022 Sep;
18(9):e1010876.
PMID: 36178969
The SARS-CoV-2 Delta Variant of Concern is highly transmissible and contains mutations that confer partial immune escape. The emergence of Delta in North America caused the first surge in COVID-19...
15.
Safdar N, Munoz-Price S, Golden R, Kerschner J, Nattinger A, Westergaard R
WMJ
. 2021 Oct;
120(3):171-173.
PMID: 34710293
No abstract available.
16.
Bigouette J, Ford L, Pray I, Langolf K, Kahrs J, Zochert T, et al.
Open Forum Infect Dis
. 2021 Oct;
8(10):ofab472.
PMID: 34692890
Background: Serial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing has been implemented at institutions of higher education (IHEs) and other settings. Testing strategies can include algorithms specifying confirmatory reverse-transcription...
17.
Segaloff H, Cole D, Rosenblum H, Lee C, Morgan C, Remington P, et al.
Open Forum Infect Dis
. 2021 Sep;
8(9):ofab405.
PMID: 34552995
Background: Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks occurred at universities during Fall 2020, but little is known about risk factors for campus-associated infections or immunity provided by...
18.
Hershow R, Segaloff H, Shockey A, Florek K, Murphy S, DuBose W, et al.
MMWR Morb Mortal Wkly Rep
. 2021 Apr;
70(13):478-482.
PMID: 33793462
SARS-CoV-2, the virus that causes COVID-19, can spread rapidly in prisons and can be introduced by staff members and newly transferred incarcerated persons (1,2). On September 28, 2020, the Wisconsin...
19.
Owusu D, Pomeroy M, Lewis N, Wadhwa A, Yousaf A, Whitaker B, et al.
J Infect Dis
. 2021 Mar;
224(8):1362-1371.
PMID: 33649773
Background: To better understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding and infectivity, we estimated SARS-CoV-2 RNA shedding duration, described participant characteristics associated with the first negative rRT-PCR test...
20.
Pray I, Kocharian A, Mason J, Westergaard R, Meiman J
MMWR Morb Mortal Wkly Rep
. 2021 Jan;
70(4):114-117.
PMID: 33507887
During September 3-November 16, 2020, daily confirmed cases of coronavirus disease 2019 (COVID-19) reported to the Wisconsin Department of Health Services (WDHS) increased at a rate of 24% per week,...